Share Facebook Twitter LinkedIn Pinterest Telegram Email Expedia cuts full-year revenue forecast due to slow B2C growth Source link See also US FDA approves Bristol Myers drug to treat colorectal cancer From Reuters B2C cuts due Expedia Forecast fullyear growth revenue Slow
